CellGenix Competitors and Similar CompaniesClear all

CellGenix's competitors and similar companies include Biocytogen Boston, Aglaris, SkinAxis and TagCyx Biotechnologies.
CellGenix
CellGenix
CellGenix is a supplier of raw and ancillary materials for the market of cell and gene therapy and regenerative medicine.
Biocytogen Boston
Biocytogen Boston
Biocytogen Boston is a company that provides antibody drug development solutions.
Aglaris
Aglaris
Aglaris is a company automating and controlling the cell culture processes.
SkinAxis
SkinAxis
SkinAxis is a biotechnology company that provides multicellular skin equivalent systems.
TagCyx Biotechnologies
TagCyx Biotechnologies
TagCyx Biotechnologies is a company developing DNA aptamers for therapeutic purposes.
Founding Date
Founding Date
1994
Founding Date
2008
Founding Date
2012
Founding Date
2013
Founding Date
2007
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Freiburg im Breisgau, DE HQ
Newington, US
Locations
Waltham, US HQ
Beijing, CN
Nantong, CN
Shanghai, CN
Heidelberg, DE
San Diego, US
San Francisco, US
Locations
Stevenage, GB HQ
Tres Cantos, ES
Locations
Hanover, US HQ
Locations
Meguro City, JP HQ
Employees
Employees
711% increase
Employees
1833% increase
Employees
13
Employees
1
Employees
4

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 284.3m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 4.9m
For sources of this data, please see the company profile

View Company Profiles

Biocytogen Boston
HQ
Waltham, US

Biocytogen Boston is a company that provides antibody drug development solutions.

View company
Aglaris
HQ
Stevenage, GB
Employees
13

Aglaris is a company automating and controlling the cell culture processes.

View company
SkinAxis
HQ
Hanover, US
Employees
1

SkinAxis is a biotechnology company that provides multicellular skin equivalent systems.

View company
TagCyx Biotechnologies
HQ
Meguro City, JP
Employees
4

TagCyx Biotechnologies is a company developing DNA aptamers for therapeutic purposes.

View company